[Long-term cardioprotective effect of nitric oxide: the role of HSP70].
Malyshev
I Iu
IIu
Maleniuk
E B
EB
Manukhina
E B
EB
Mikoian
V D
VD
Vanin
A F
AF
D000818:Animals; D018840:HSP70 Heat-Shock Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007501:Iron / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D017202:Myocardial Ischemia / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism*; D009569:Nitric Oxide / Q000502:physiology*; D009589:Nitrogen Oxides / Q000378:metabolism / Q000494:pharmacology; D011794:Quercetin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D018840:HSP70 Heat-Shock Proteins; D009589:Nitrogen Oxides; D009569:Nitric Oxide; C073661:dinitrosyl iron complex; D011794:Quercetin; D007501:Iron
Dolgosrochnyĭ kardioprotektornyĭ éffekt oksida azota: rol' HSP70.